Lee Daniel Flynn Net Worth & Insider Trades

Lee Daniel Flynn - Chief Scientific Officer, Deciphera Pharmaceuticals, Inc

As of June 21, 2023

What is Lee Daniel Flynn's Net Worth?

The current estimated net worth of Deciphera Pharmaceuticals, Inc's Chief Scientific Officer, Lee Daniel Flynn, is estimated to be about $30.32M . Lee Daniel Flynn owns about 106,646 units of Deciphera Pharmaceuticals, Inc common stock. In the last 5 years at Deciphera Pharmaceuticals, Inc, Lee Daniel Flynn has sold an estimated value of $29M worth.

What is Lee Daniel Flynn's Past Insider Trading?

Lee Daniel Flynn's largest purchase order was 152,927 units , worth over $289.03K on December 11, 2019. Lee Daniel Flynn's largest sale order was 152,927 units , worth over $8.41M on December 11, 2019. In total, Lee Daniel Flynn has made about 23 transactions over 5 years of their time at Deciphera Pharmaceuticals, Inc. Lee Daniel Flynn usually trades in February, with the busiest year in 2019. The most recent transaction was a sale order of 1,655 units , worth over $23.83K on June 21, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lee Daniel Flynn

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Lee Daniel Flynn's' Mailing Address?

  • Mailing address is C/o Deciphera Pharmaceuticals, Llc 500 Totten Pond Road Waltham MA 02451 MA

Deciphera Pharmaceuticals, Inc Executive Compensation

Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Steven L. Hoerter 2020 $650,000 - - $6,597,306 $536,250 $11,388 $7,794,944
Steven L. Hoerter 2019 $449,886 - $1,320,800 $6,776,000 $478,500 - $9,025,186
Thomas P. Kelly 2020 $447,200 - $386,285 $1,546,335 $272,278 $7,386 $2,659,484
Thomas P. Kelly 2019 $430,000 - - $1,308,788 $336,690 $11,200 $2,086,678
Thomas P. Kelly 2018 $370,000 - - $1,755,252 $175,000 $11,000 $2,311,252
Matthew L. Sherman, M.D. 2020 $504,986 - $96,571 $385,576 $307,461 $5,962 $1,300,556
Matthew L. Sherman, M.D. 2019 $125,000 $150,000 $1,205,050 $3,458,715 $84,593 $115,164 $5,138,522
Daniel L. Flynn, Ph.D. 2020 $442,000 - $386,285 $1,546,335 $269,112 $11,400 $2,655,132
Daniel C. Martin 2020 $436,800 - $386,285 $1,546,335 $247,141 $23,882 $2,640,443
Daniel C. Martin 2019 $420,000 - - $907,426 $253,344 $505,549 $2,086,319
Daniel C. Martin 2018 $117,875 $100,000 $722,000 $2,189,097 $45,000 $702 $3,174,674
Stephen B. Ruddy, Ph.D. 2020 $383,400 - $386,285 $1,546,335 $216,928 $1,212 $2,534,160
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1654151/000165415121000007/dcph-2021xproxystatement.htm

What are Deciphera Pharmaceuticals, Inc's Past Insider Trades?

Deciphera Pharmaceuticals, Inc's most recent insider trade came on June 21, 2023 by Jama Pitman who sold 1,238 units worth $17.83K . In the last 6 years, insiders at Deciphera Pharmaceuticals, Inc have sold an estimated value of $103.47M and bought an estimated value of $63.62M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Douglas Michael Taylor, Director,  Patrick Thomas Kelly, Chief Financial Officer,  and Lee Daniel Flynn, Chief Scientific Officer .

Deciphera Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found